• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,550.25 918.60
( 1.20%)
Global Indices
Nasdaq
47,930.49 -276.32
(-0.57%)
Dow Jones
6,837.38 -8.28
(-0.12%)
Hang Seng
56,916.27 1,020.95
(1.83%)
Nikkei 225
10,596.33 -7.15
(-0.07%)
Forex
USD-INR
92.50 0.06
(0.07%)
EUR-INR
108.05 0.09
(0.08%)
GBP-INR
124.08 0.03
(0.03%)
JPY-INR
0.58 0.00
(-0.25%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-9.9177201
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
207.33
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

amerise biosciences ltd
NAHAGENCO-NTPC consortium complete acquisition of 1350 MW Sinnar Thermal Power
Feb 25,2026

The consortium of Maharashtra State Power Generation Company (MAHAGENCO) and NTPC have completed the acquisition of Sinnar Thermal Power (STPL), a company which was undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code 2016 (IBC), in terms of the NCLT approved Resolution Plan.

STPL owns a coal based thermal power plant of 5X270 MW (1350MW) capacity at Sinnar, Nashik, Maharashtra.

With completion of aforesaid transaction, the total installed capacity of NTPC group stands at 88,132 MW and commercial capacity at 87,052 MW.